Diabetes Management

Toward Standardized Type 2 Diabetes Treatment Decisions: Diabetologist Evaluation of an Evidence-Citing Agentic AI for Real-World Care

by Prateek Chopra | June 28, 2026 | Diabetes Conferences | ADA 2026 Innovation Overview Key Functionalities Evaluation Approach Clinician Acceptability Ratings (Score ≥4) Key Findings Clinical Implications The agentic AI system generated evidence-based T2D treatment recommendations with high clinician acceptability across multiple decision-making domains. These findings highlight its potential to support standardized, reliable, and evidence-informed diabetes care in clinical […]

Toward Standardized Type 2 Diabetes Treatment Decisions: Diabetologist Evaluation of an Evidence-Citing Agentic AI for Real-World Care Read Post »

Leave a Comment / Diabetes Conferences / / / , , , , ,

Real-World Evaluation of a Personalized, Multilingual Digital Diabetes Care Model across Metropolitan and Nonmetropolitan India

by Prateek Chopra | June 27, 2026 | Diabetes Conferences | ADA 2026 Program Overview Program Features Methods Study Population Engagement Patterns Clinical Outcomes Age-Stratified Findings Clinical Implications The Sugar.fit multilingual digital diabetes program achieved high engagement and clinically meaningful improvements in glycemic control and weight across both metropolitan and nonmetropolitan populations. These findings support the scalability and equity of

Real-World Evaluation of a Personalized, Multilingual Digital Diabetes Care Model across Metropolitan and Nonmetropolitan India Read Post »

Leave a Comment / Diabetes Conferences / / / , , , ,

CGM for Adults with Type 2 Diabetes Not on Insulin Therapy: The CONNECT Randomized Controlled Trial

by Prateek Chopra | June 24, 2026 | Diabetes Conferences | ADA 2026 Study Objective Trial Design Study Assessments Baseline Characteristics Baseline Medication Use Clinical Implications Baseline findings from the CONNECT trial highlight persistent gaps in glycemic management among adults with non-insulin-treated T2D. The ongoing study will determine whether CGM can improve glycemic outcomes and support more effective diabetes management

CGM for Adults with Type 2 Diabetes Not on Insulin Therapy: The CONNECT Randomized Controlled Trial Read Post »

Leave a Comment / Diabetes Conferences / / / , , , , ,

The Hypoglycemia Prevention Program (HPP) for Primary Care: Pilot Clinical Trial

by Prateek Chopra | June 22, 2026 | Diabetes Conferences | ADA 2026 | 0 comments Clinical Need Program Overview Intervention Components Patient Participation Key Findings Clinical Implications The EHR-integrated HPP was well accepted by patients and improved hypoglycemia prevention practices in primary care. Further studies are warranted to determine its long-term impact on reducing hypoglycemic events.

The Hypoglycemia Prevention Program (HPP) for Primary Care: Pilot Clinical Trial Read Post »

Leave a Comment / Diabetes Conferences / / / , , , ,

Interventions and Approaches to Type 2Diabetes Treatment

by Prateek Chopra | June 11, 2026 | Diabetes Conferences | ADA 2026 | 0 comments Treatment Paradigm Shift: Role of SGLT2 Inhibitors: Role of GLP-1 Receptor Agonists: Established Glucose-Lowering Therapies: Metformin: Sulfonylureas: Insulin: Principles of Individualized Care: Contemporary T2DM management extends beyond glycemic control to address cardiovascular, renal, and metabolic health. Individualized treatment strategies

Interventions and Approaches to Type 2Diabetes Treatment Read Post »

Leave a Comment / Diabetes Conferences / / / , , , ,

Cost-Effectiveness of Age-Specific Remote Education to Initiate and Sustain Use of CGM in Older Adults with Diabetes on Insulin

by Prateek Chopra | June 11, 2026 | Diabetes Conferences | ADA 2026 | 0 comments Modeling Approach: Intervention: Projected Clinical Outcomes: Benefits in Type 1 Diabetes: Benefits in Type 2 Diabetes: Quality of Life and Economic Outcomes: Clinical Implications: Long-term projections based on the REST intervention demonstrated meaningful reductions in diabetes- and cardiovascular-related complications,

Cost-Effectiveness of Age-Specific Remote Education to Initiate and Sustain Use of CGM in Older Adults with Diabetes on Insulin Read Post »

Leave a Comment / Diabetes Conferences / / / , , , ,

Movement Breaks Improve Cardiovascular Risk Factors in Adults with Type 2 Diabetes: A Randomized Controlled Trial

by Prateek Chopra | June 11, 2026 | Diabetes Conferences | ADA 2026 | 0 comments Study Design: A 12-week randomized trial evaluated the impact of brief daily movement breaks on achievement of the ABC diabetes care targets in adults with type 2 diabetes (T2D). A total of 69 participants (46 women and 23 men)

Movement Breaks Improve Cardiovascular Risk Factors in Adults with Type 2 Diabetes: A Randomized Controlled Trial Read Post »

Leave a Comment / Diabetes Conferences / / / , , , ,
Scroll to Top